Our business
Contribute to the realization of cancer drug leads from academia
HOIST Corp. is developing anti-cancer products with novel mechanism-of-action utilizing the MA-T® system. Further, we are pursuing epitranscriptomics drug discovery via a novel target, ALKBH. In addition, we run a drug discovery support business for our clients creating patient derived cells (PDC) / patient derived xenografts (PDX).
In pharmaceutical development, HOIST Corp. aims to utilize partnerships with pharmaceutical companies (via licensing-out, joint drug discovery etc.). In the drug discovery support business, we tailor PDC/PDX solutions to individual needs of our clients, and contribute to higher success rate of product development.
- View PDF
- Click image to enlarge
MA-T® system is an abbreviation for Matching Transformation System®, which is a way to control oxidation that generates the requisite amount of aqueous radicals from chlorite ions when required. “Japan MA-T Industrial Association” was established to improve and promote MA-T®, and HOIST Corp. is a member of this organization.